Navigation Links
myoscience Announces Robert Grant as Chairman of the Board
Date:1/6/2012

REDWOOD CITY, Calif., Jan. 6, 2012 /PRNewswire/ -- myoscience, Inc. of Redwood City, California is pleased to announce the appointment of Robert E. Grant as Chairman of the Board of Directors effective January 1st, 2012.  Mr. Grant was formerly Chief Executive Officer and President of Bausch & Lomb Surgical and President of Allergan Medical, a division of Allergan.  Mr. Grant has been a board member for myoscience since November 2010 and this latest announcement is a reflection of the company's continuing development as a commercial company in the global aesthetics market.

"We are pleased that Robert has agreed to take the Chairman's role at this important stage of our success.  I have the utmost respect for his strategic talent and his deep understanding of the medical device and pharmaceutical markets," said Clint Carnell, President and Chief Executive Officer of myoscience. "I would also like to thank Rich Ferrari of DeNovo Ventures.  Rich led the Board since its inception and we look forward to his continued contributions as a myoscience board member."

"myoscience's next generation, toxin-free approach to treating nerves for aesthetic and therapeutic applications represents a major advance in neuromodulation. Clint is an adept leader and manager.  He has assembled a talented management team and positioned the company for international commercial launch following recent regulatory approvals in both the EU and Canada," said Mr. Grant. 

About myoscience. myoscience is a privately held medical device company dedicated to developing innovative treatments in whichever fields it chooses to enter. The myoscience technology is currently approved in Europe and Canada for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions and focal cryo-treatment of tissue.  The myoscience technology has also been cleared in the US for use in pain management and general surgical use. www.myoscience.com

Contact:
Matt Franklin, 1-650-421-0671  


'/>"/>
SOURCE myoscience, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. VirtualScopics Announces Receipt of Notice from Nasdaq
2. Breckenridge Announces Seven Paragraph IV ANDAs in 2011
3. Radient Pharmaceuticals Announces New Advertisement for Oncology Publications
4. Pearl Therapeutics Announces Successful Completion of Phase 2b Safety and Efficacy Studies of COPD Combination, PT003
5. Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA®
6. Cascade Medical Enterprises, LLC Announces the Sale of Their Orthopedic Business
7. Tris Pharma Announces US Patent Grant Covering Platform Technology
8. BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine
9. DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial)
10. Acella Pharmaceuticals, LLC Announces Its Acquisition of the PRENATE® Family of Trademarks and Associated Intellectual Property
11. ResMed Announces Conference Call and Webcast to Discuss Second Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
(Date:6/24/2016)... CHAPEL HILL, N.C. , June 24, 2016 ... in healthcare decisions and regulators/payers have placed more ... this new environment, patient support programs in the ... support for patients, medications. Consequently, pharmaceutical companies are ... to ensure they are providing products and services ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, affiliated ... Weintraub as a prominent plastic surgeon and the network’s newest partner. , ... most handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands ...
Breaking Medicine News(10 mins):